Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 553

1.

Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.

Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhang W, Zhou Y, Hong JS, Zhang J.

FASEB J. 2005 Apr;19(6):533-42.

PMID:
15791003
2.

Femtomolar concentrations of dextromethorphan protect mesencephalic dopaminergic neurons from inflammatory damage.

Li G, Cui G, Tzeng NS, Wei SJ, Wang T, Block ML, Hong JS.

FASEB J. 2005 Apr;19(6):489-96.

PMID:
15790998
3.
4.

NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia.

Qin L, Liu Y, Wang T, Wei SJ, Block ML, Wilson B, Liu B, Hong JS.

J Biol Chem. 2004 Jan 9;279(2):1415-21. Epub 2003 Oct 24.

5.

3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity.

Zhang W, Qin L, Wang T, Wei SJ, Gao HM, Liu J, Wilson B, Liu B, Zhang W, Kim HC, Hong JS.

FASEB J. 2005 Mar;19(3):395-7. Epub 2004 Dec 13.

PMID:
15596482
6.

Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease.

Gao HM, Liu B, Zhang W, Hong JS.

FASEB J. 2003 Oct;17(13):1954-6. Epub 2003 Aug 1.

PMID:
12897068
7.

[Role of microglial activation induced by α-synuclein in pathogenesis of Parkinson's disease].

Qiao S, Luo JH, Jin JH.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2012 Mar;41(2):210-4. Review. Chinese.

PMID:
22499522
8.
9.

Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein.

Zhang W, Dallas S, Zhang D, Guo JP, Pang H, Wilson B, Miller DS, Chen B, Zhang W, McGeer PL, Hong JS, Zhang J.

Glia. 2007 Aug 15;55(11):1178-88.

PMID:
17600340
10.

Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions.

Zhang F, Shi JS, Zhou H, Wilson B, Hong JS, Gao HM.

Mol Pharmacol. 2010 Sep;78(3):466-77. doi: 10.1124/mol.110.064535. Epub 2010 Jun 16. Erratum in: Mol Pharmacol. 2010 Nov;78(5):981.

11.

Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP.

Kim S, Cho SH, Kim KY, Shin KY, Kim HS, Park CH, Chang KA, Lee SH, Cho D, Suh YH.

J Neurochem. 2009 Jun;109(5):1483-96. doi: 10.1111/j.1471-4159.2009.06075.x. Epub 2009 Mar 30.

13.

Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson's disease.

Park JY, Paik SR, Jou I, Park SM.

Glia. 2008 Aug 15;56(11):1215-23. doi: 10.1002/glia.20691.

PMID:
18449945
14.

Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia.

Peng GS, Li G, Tzeng NS, Chen PS, Chuang DM, Hsu YD, Yang S, Hong JS.

Brain Res Mol Brain Res. 2005 Mar 24;134(1):162-9. Epub 2004 Nov 25.

PMID:
15790540
15.
16.
17.

Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity.

Zhang D, Hu X, Wei SJ, Liu J, Gao H, Qian L, Wilson B, Liu G, Hong JS.

J Neuroinflammation. 2008 May 28;5:21. doi: 10.1186/1742-2094-5-21.

18.

Fluoxetine prevents LPS-induced degeneration of nigral dopaminergic neurons by inhibiting microglia-mediated oxidative stress.

Chung ES, Chung YC, Bok E, Baik HH, Park ES, Park JY, Yoon SH, Jin BK.

Brain Res. 2010 Dec 2;1363:143-50. doi: 10.1016/j.brainres.2010.09.049. Epub 2010 Sep 18.

PMID:
20858471

Supplemental Content

Support Center